BBP icon

Virtus LifeSci Biotech Products ETF
BBP

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $4.83M invested in Virtus LifeSci Biotech Products ETF in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.43M
2
+$298K
3
+$35.6K

Top Sellers

1
-$1.19M
2
-$211K
3
-$66.7K
4
UBS Group
UBS Group
Switzerland
-$44.1K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$33K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.8M
2
$862K
3
$770K
4
$629K
5
$268K
6
$217K
7
$136K
8
$61K
9
$27K
10
$26.3K
11
$10.2K
12
$9.86K
13
$8.62K
14
$2.27K
15
–
16
–
17
–